Robert Edwards

8.2k total citations · 1 hit paper
27 papers, 1.2k citations indexed

About

Robert Edwards is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Robert Edwards has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Robert Edwards's work include Diabetes Treatment and Management (13 papers), Pancreatic function and diabetes (8 papers) and Metabolism, Diabetes, and Cancer (5 papers). Robert Edwards is often cited by papers focused on Diabetes Treatment and Management (13 papers), Pancreatic function and diabetes (8 papers) and Metabolism, Diabetes, and Cancer (5 papers). Robert Edwards collaborates with scholars based in United States, United Kingdom and Australia. Robert Edwards's co-authors include Gary Meininger, Keith Usiskin, Mehul Desai, John P. Bilezikian, Gordon Law, Nelson B. Watts, Norman Rosenthal, Meg Jardine, Kenneth W. Mahaffey and Vlado Perkovic and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Robert Edwards

25 papers receiving 1.1k citations

Hit Papers

Effects of Canagliflozin on Fracture Risk in Patients Wit... 2015 2026 2018 2022 2015 100 200 300

Peers

Robert Edwards
Jenny E. Blau United States
Norm Rosenthal United States
Silvina Gallo United States
Bruce R. Leslie United States
W. Marz Germany
Jenny E. Blau United States
Robert Edwards
Citations per year, relative to Robert Edwards Robert Edwards (= 1×) peers Jenny E. Blau

Countries citing papers authored by Robert Edwards

Since Specialization
Citations

This map shows the geographic impact of Robert Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Edwards more than expected).

Fields of papers citing papers by Robert Edwards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Edwards. The network helps show where Robert Edwards may publish in the future.

Co-authorship network of co-authors of Robert Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Edwards. A scholar is included among the top collaborators of Robert Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Edwards. Robert Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neuen, Brendon L., Megumi Oshima, Vlado Perkovic, et al.. (2021). Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial. European Heart Journal. 42(48). 4891–4901. 86 indexed citations
2.
Oshima, Megumi, Meg Jardine, Rajiv Agarwal, et al.. (2020). Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice. Kidney International. 99(4). 999–1009. 114 indexed citations
3.
Zhou, Zien, Meg Jardine, Qiang Li, et al.. (2020). EFFECTS OF CANAGLIFLOZIN ON STROKE IN THE CREDENCE TRIAL. Journal of the American College of Cardiology. 75(11). 215–215. 2 indexed citations
4.
Oshima, Megumi, Brendon L. Neuen, Meg Jardine, et al.. (2020). Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial. The Lancet Diabetes & Endocrinology. 8(11). 903–914. 88 indexed citations
5.
Oshima, Megumi, Brendon L. Neuen, Jingwei Li, et al.. (2020). Early Change in Albuminuria with Canagliflozin (CANA) Predicts Kidney and Cardiovascular (CV) Outcomes. Journal of the American Society of Nephrology. 31(10S). 344–344. 1 indexed citations
6.
Edwards, Robert, et al.. (2020). Haptic Abilities and Their Impact on Teaching and Learning in the STEM Fields. Papers on Engineering Education Repository (American Society for Engineering Education). 24.662.1–24.662.5. 1 indexed citations
7.
Oshima, Megumi, Brendon L. Neuen, Jingwei Li, et al.. (2020). Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial. Journal of the American Society of Nephrology. 31(12). 2925–2936. 109 indexed citations
8.
Wheeler, DC, Rajiv Agarwal, G. Bakris, et al.. (2018). The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale and design. UCL Discovery (University College London). 3 indexed citations
10.
Rosenthal, Norm, Gary Meininger, Kirk Ways, et al.. (2015). Canagliflozin: a sodium glucose co‐transporter 2 inhibitor for the treatment of type 2 diabetes mellitus. Annals of the New York Academy of Sciences. 1358(1). 28–43. 79 indexed citations
11.
Watts, Nelson B., John P. Bilezikian, Keith Usiskin, et al.. (2015). Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 101(1). 157–166. 337 indexed citations breakdown →
12.
Edwards, Robert, et al.. (2014). Effects of L-Theanine on Posttraumatic Stress Disorder Induced Changes in Rat Brain Gene Expression. The Scientific World JOURNAL. 2014. 1–10. 8 indexed citations
13.
Weir, Matthew R., Irina Kline, John Xie, Robert Edwards, & Keith Usiskin. (2014). Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR). Current Medical Research and Opinion. 30(9). 1759–1768. 96 indexed citations
14.
Stenlöf, Kaj, William T. Cefalu, Kyoung‐Ah Kim, et al.. (2013). Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study. Current Medical Research and Opinion. 30(2). 163–175. 141 indexed citations
15.
Flament, O., B. Brichard, Andrew Michael Chugg, et al.. (2007). Radiation effects in future electronics from device to systems — Roundtable report. 26–30. 1 indexed citations
16.
Edwards, Robert, W A Ratcliffe, J. Walls, et al.. (1995). Parathyroid hormone-related protein (PTHrP) in breast cancer and benign breast tissue. European Journal of Cancer. 31(3). 334–339. 13 indexed citations
17.
Walls, J., et al.. (1993). Parathyroid hormone-related protein: cytosol extraction in breast cancer and normal breast tissue. The Breast. 2(3). 203–203. 1 indexed citations
18.
Nahata, Milap C., et al.. (1991). Prolonged Sedation Associated with Secobarbital in Newborn Infants Receiving Ventilatory Support. American Journal of Perinatology. 8(1). 35–36. 3 indexed citations
19.
Nahata, Milap C., et al.. (1988). Developmental aspects of phenobarbital dosage requirements in newborn infants with seizures.. PubMed. 8(4). 318–20. 10 indexed citations
20.
Cassar, J., Robert Edwards, Κ. Mashiter, & E M Kohner. (1975). BROMOCRIPTINE AND SERUM-GROWTHHORMONE LEVELS IN DIABETES MELLITUS. The Lancet. 306(7926). 181–181. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026